Abstract

Decellularized extracellular matrix (ECM) derived from tissues and organs are emerging as important scaffold materials for regenerative medicine. Many believe that preservation of the native ECM structure during decellularization is highly desirable. However, because effective techniques to assess the structural damage in ECM are lacking, the disruptive effects of a decellularization method and the impact of the associated structural damage upon the scaffold’s regenerative capacity are often debated. Using a novel collagen hybridizing peptide (CHP) that specifically binds to unfolded collagen chains, we investigated the molecular denaturation of collagen in the ECM decellularized by four commonly used cellremoving detergents: sodium dodecyl sulfate (SDS), 3-[(3-cholamidopropyl)dimethylammonio]-1-propa nesulfonate (CHAPS), sodium deoxycholate (SD), and Triton X-100. Staining of the detergent-treated porcine ligament and urinary bladder matrix with carboxyfluorescein-labeled CHP demonstrated that SDS and Triton X-100 denature the triple helical collagen molecule while CHAPS and SD do not, although second harmonic generation imaging and transmission electron microscopy (TEM) revealed that all four detergents disrupt collagen fibrils. Our findings from the CHP staining were further confirmed by the circular dichroism spectra of intact triple helical collagen molecules in CHAPS and SD solutions, and the TEM images of CHP-conjugated gold nanoparticles binding only to the SDS and Triton X-100 treated collagen fibrils. CHP is a powerful new tool for direct and reliable measurement of denatured collagen molecules in decellularized tissues. It is expected to have wide applications in the development and standardization of the tissue/organ decellularization technology.Statement of SignificancePreservation of the native ECM structure in decellularized tissues is highly desirable, since denaturation of ECM molecules (e.g., collagen) during decellularization can strongly influence the cellular response. Unfortunately, conventional techniques (SEM, SHG) are not conducive to identifying denatured collagen molecules in tissues. We demonstrate the first investigation into the molecular denaturation of collagen in decellularized ECM enabled by a novel Collagen Hybridizing Peptide (CHP) that specifically binds to unfolded collagen chains. We show that SDS and Triton X-100 denature collagen molecules while CHAPS and SD cannot. Such detection has been nearly impossible with other existing techniques. The CHP technique will advance our understanding about the effect of the cell-removing process on ECM, and lead to development of the decellularization technology.

Highlights

  • Extracellular matrix (ECM) obtained by the decellularization of tissues has become an important biomaterial for tissue engineering and regenerative medicine [1]

  • The CF-labeled sequence-scrambled control peptide (CF-SSCP) showed no affinity to the sodium dodecyl sulfate (SDS)-treated tissue (Fig. 1 top right corner), confirming that the binding of CF-collagen hybridizing peptide (CHP) was truly due to the triple helical hybridization between CHP and the collagen molecules unfolded by the SDS treatment

  • These results demonstrated that the denaturation effect of SDS on collagen molecules is attenuated at lower concentrations, and that the different levels of collagen denaturation in detergent treated tissues can be distinguished by CHP staining

Read more

Summary

Introduction

Extracellular matrix (ECM) obtained by the decellularization of tissues has become an important biomaterial for tissue engineering and regenerative medicine [1]. One example is the use of decellularized myocardial matrix hydrogels as a post-myocardial infarction biomaterial therapy [8] This new therapy has produced encouraging preclinical results [9,10] and is currently under a clinical trial [6]. Improvement in whole organ decellularization techniques has enabled 3D organ scaffolds, which preserve the native tissue architecture including vascular networks [11,12]. These decellularized scaffolds can be repopulated with selected cell types in vitro to regenerate functional organs. In light of critical shortage of organ donors, this technological breakthrough provides hopes of transplanting engineered animal organs to patients with end-stage organ failure

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.